| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.2 | 2e-07 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.15 | 7e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0002 |